The following are today's upgrades for Validea's Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth that trade at a discount relative to their earnings growth and dividend yield.
Just a few months after T-Mobile (NASDAQ: TMUS) closed its acquisition of Sprint to become a more formidable competitor to AT&T and Verizon (NYSE: VZ), Verizon announced on Monday that it is acquiring Tracfone from America Movil (NYSE: AMX). Tracfone is the largest mobile v
Ant Group, the Alibaba (NYSE: BABA)-backed fintech company that owns the digital payments platform Alipay, will soon go public in one of the biggest IPOs in history. Ant was valued at $150 billion after its last funding round in 2018 and could hit a valuation of $200 billion in
To say that negotiations on another COVID-19 relief package haven't gone well would be an understatement. Talks between Democratic and Republican leaders have gone nowhere, even after the enhanced unemployment benefits and several other provisions of the first stimulus package e
(RTTNews) - Shares of Roku, Inc. (ROKU), the San Jose-based video streaming hardware provider, are gaining on Tuesday morning trade despite no company-specific news.
(RTTNews) - Amazon.com has rebranded its Amazon FreeTime and Amazon FreeTime Unlimited services as Amazon Kids and Amazon Kids+, respectively. These two services provide a kid-friendly experience for families with books, games, shows, and movies.
The two services have enabled
(RTTNews) - Shares of InMode Ltd. (INMD) are up more than 5 percent or $1.91 in Tuesday's morning trade at $37.96 despite no specific news that could influence the company's stock.
One of the biggest winners among coronavirus stocks in 2020 has been Vir Biotechnology (NASDAQ: VIR). The company's shares have more than doubled in the span of one year, turning a $10,000 investment from last September into about $22,700 today. That substantially outperformed
(RTTNews) - Amazon announced Tuesday that it is expanding its computer science education program, Amazon Future Engineer, to more than 5,000 schools across the U.S., benefiting over 550,000 K-12 students each year.
Biogen (NASDAQ: BIIB) hasn't had the best year -- and not necessarily because of the COVID-19 pandemic. Back in June, a judge invalidated a patent on Tecfidera, which is the biotech's best-selling drug. Because of this decision, Biogen will face generic competition for Tecfidera
The marijuana industry has been on a roller-coaster ride since 2019 -- a dreadful year that pulled the industry benchmark, the Horizons Marijuana Life Sciences ETF (OTC: HMLSF), down by 36%. Regulatory delays, particularly in Canada, were a large reason for the decline, because
Seemingly every avid gambler has a system -- a way to beat the odds, or at least make them feel smarter than the average bear. Traders feel the same way. They're buying dips and have strong convictions about what a company's share price will do after it reports earnings.
PARIS/LONDON (Reuters Breakingviews) - Who would have thought that sewage would keep the Parisian investment-banking elite in their Hermès ties? But a hostile bid launched in the lazy days of a pandemic summer by Veolia for control of its waste and water treatment rival
Many investors have long hoped that Gilead Sciences (NASDAQ: GILD) would use its massive cash stockpile to fund a major acquisition. That hope is now being fulfilled.
How long does it take stocks to double? The S&P 500 index has delivered an average annual return of around 10%. That translates to roughly seven years for the index to double.
Warren Buffett may very well be the most successful investor alive today. As CEO of Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B), Buffett has led his company to an annualized return of 20.3% over the past 55 years. For some context here, that's more than double the 10% compound
Checked
6 minutes 1 second ago
This feed is responsible for generating the rss feed related to the topic Markets